![]() |
市場調查報告書
商品編碼
1836345
2032 年神經監測市場預測:按產品、模式、應用、最終用戶和地區進行的全球分析Neurology Monitoring Market Forecasts to 2032 - Global Analysis By Product, Modality, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球神經監測市場預計在 2025 年達到 108 億美元,到 2032 年將達到 187 億美元,預測期內的複合年成長率為 8.15%。
神經監測是指對神經系統功能進行持續或定期評估,以檢測、評估和管理神經系統疾病。它使用先進的診斷工具,包括腦電圖 (EEG)、肌電圖 (EMG)、顱內壓監測和腦血氧飽和度監測,追蹤大腦、脊髓和周邊神經活動。這種監測在重症加護、手術全期和慢性神經系統疾病中至關重要,能夠及早發現異常,及時介入並改善患者預後。透過提供即時數據,神經監測支持明智的臨床決策,並提高神經系統治療的有效性。
神經系統疾病盛行率不斷上升
神經系統疾病的日益流行,加速了醫院和家庭護理機構對即時、非侵入性診斷工具的需求。癲癇、帕金森氏阿茲海默症、阿茲海默症和中風等疾病正在推動腦電圖 (EEG)、肌電圖 (EMG) 和顱內壓監測儀的應用。與人工智慧 (AI) 和遠端監控平台的整合正在提高診斷準確性和患者預後。人口老化和生活方式相關的神經系統風險正在擴大可治療的患者群體。
先進監控設備高成本
先進監測設備的高成本降低了小型診所和新興市場的可負擔性。安裝、校準和維護費用限制了採購週期。神經系統診斷的報銷和預算分配有限,阻礙了機構的採用。製造商必須在創新與成本效益之間取得平衡。這些限制因素阻礙了下一代監測平台的採用。
新興國家醫療投資增加
新興國家醫療保健投資的增加正在加速腦電圖 (EEG)、肌電圖 (EMG) 和腦血氧儀系統的部署。政府和私人醫療機構正在透過遠端醫療和遠端監控計劃擴展神經病學能力。對神經系統疾病早期發現和長期管理的需求正在推動設備採購。本地製造和官民合作關係正在提高醫療服務的可負擔性和服務水準。
不利的報銷政策
不利的報銷政策正在削弱醫院和診斷中心的財務可行性。神經系統手術和設備的保險覆蓋範圍不一致,限制了病患的就醫管道和醫療機構的獎勵。圍繞設備分類和使用通訊協定的監管模糊性正在減緩核准。支付系統碎片化和成本控制壓力正在減少對先進監控基礎設施的投資。這些因素正在減緩成本敏感型醫療保健系統的採用。
新冠疫情加速了對免疫支持和低糖產品的需求,並引發了人們對植物性甜味劑的興趣。封鎖措施和對健康的擔憂使消費轉向機能飲料和家庭自製食品。供應鏈中斷暫時惡化了關鍵植物成分的可得性和採購。疫情後的復甦正在推動對本地生產和潔淨標示創新的投資。數位零售和健康平台正在擴大消費者的獲取管道和教育。這場危機推動了天然甜味劑從小眾市場走向主流。
預測期內,腦電圖 (EEG) 設備市場預計將成為最大的市場
腦電圖 (EEG) 設備領域預計將在預測期內佔據最大的市場佔有率,這得益於其在診斷和監測多種病症的腦活動方面的多功能性。癲癇、睡眠障礙和神經退化性疾病領域的應用正在推動其在機構和門診環境中的應用。與攜帶式和雲端連接格式的整合正在提高可用性和資料可存取性。醫院、神經科科診所和研究中心正在擴展其腦電圖基礎設施以進行即時分析。訊號處理和偽影消除技術的進步正在提高診斷的準確性。該領域仍是神經監測通訊協定的基石。
穿戴式腦電圖設備領域預計將在預測期內實現最高複合年成長率
隨著遠端和持續腦監測需求的加速成長,穿戴式腦電圖設備市場預計將在預測期內實現最高成長率。與行動應用程式、雲端平台和人工智慧分析的整合正在擴大其在門診病人和居家照護環境中的應用。睡眠追蹤、癲癇發作檢測和認知評估等領域的應用正在激發消費者和臨床醫生的興趣。輕巧的外形規格和無線連接正在提高患者的舒適度和依從性。醫療科技公司與數位健康平台之間的夥伴關係正在推動認知度和普及度的提升。
在預測期內,北美預計將佔據最大的市場佔有率,這得益於其強大的醫療基礎設施、較高的診斷意識以及優惠的報銷框架。美國和加拿大正在擴大醫院、研究機構和居家照護網路中的神經監測。對人工智慧診斷和遠距神經病學平台的投資正在增強服務能力。與領先設備製造商的學術合作正在推動創新。監管的明確性和臨床整合正在增強市場主導地位。該地區將繼續成為神經診斷部署的標竿。
由於醫療保健體系的不斷擴展和神經系統疾病負擔的不斷加重,預計亞太地區在預測期內的複合年成長率最高。中國、印度、日本和東南亞正在透過公共衛生措施和私人投資推動神經監測的擴張。新興經濟體醫療保健投資的不斷增加正在加速腦電圖 (EEG)、肌電圖 (EMG) 和腦血氧儀技術的普及。穿戴式裝置和行動診斷領域的區域技術創新正在提高可負擔性和普及性。對早期檢測和長期照護的需求正在推動神經監測技術的快速普及。
According to Stratistics MRC, the Global Neurology Monitoring Market is accounted for $10.8 billion in 2025 and is expected to reach $18.7 billion by 2032 growing at a CAGR of 8.15% during the forecast period. Neurology monitoring refers to the continuous or periodic assessment of the nervous system's function to detect, evaluate, and manage neurological conditions. It involves tracking brain, spinal cord, and peripheral nerve activity using advanced diagnostic tools such as electroencephalography (EEG), electromyography (EMG), intracranial pressure monitors, and cerebral oximetry. This monitoring is essential in critical care, perioperative settings, and chronic neurological disorders, enabling early detection of abnormalities, timely intervention, and improved patient outcomes. By providing real-time data, neurology monitoring supports informed clinical decisions and enhances the effectiveness of neurological treatments.
Rising prevalence of neurological disorders
Rising prevalence of neurological disorders is accelerating demand for real-time, non-invasive diagnostic tools across hospitals and home care settings. Conditions such as epilepsy, Parkinson's, Alzheimer's, and stroke are driving adoption of EEG, EMG, and intracranial pressure monitors. Integration with AI and remote monitoring platforms is improving diagnostic accuracy and patient outcomes. Aging populations and lifestyle-related neurological risks are expanding the addressable patient base.
High cost of advanced monitoring devices
High cost of advanced monitoring devices is degrading affordability for smaller clinics and emerging markets. Installation, calibration, and maintenance expenses are constraining procurement cycles. Limited reimbursement and budget allocation for neurological diagnostics are slowing institutional adoption. Manufacturers face pressure to balance innovation with cost efficiency. These constraints are delaying widespread deployment of next-generation monitoring platforms.
Increased healthcare investments in emerging economies
Increased healthcare investments in emerging economies are accelerating deployment of EEG, EMG, and cerebral oximetry systems. Governments and private providers are scaling neurology capacity through telemedicine and remote monitoring initiatives. Demand for early detection and long-term management of neurological conditions is driving equipment procurement. Local manufacturing and public-private partnerships are improving affordability and reach.
Unfavourable reimbursement policies
Unfavorable reimbursement policies are degrading financial viability for hospitals and diagnostic centers. Inconsistent coverage for neurology procedures and devices is limiting patient access and provider incentives. Regulatory ambiguity around device classification and usage protocols is slowing approvals. Fragmented payer systems and cost-containment pressures are reducing investment in advanced monitoring infrastructure. These factors are weakening adoption momentum in cost-sensitive healthcare systems.
The Covid-19 pandemic accelerated demand for immunity-supporting and low-sugar products, boosting interest in plant-based sweeteners. Lockdowns and health concerns shifted consumption toward functional beverages and home-prepared meals. Supply chain disruptions temporarily degraded availability and sourcing of key botanical inputs. Post-pandemic recovery is fostering investment in localized production and clean-label innovation. Digital retail and wellness platforms are expanding consumer access and education. The crisis elevated natural sweeteners from niche to mainstream relevance.
The electroencephalography (EEG) devices segment is expected to be the largest during the forecast period
The electroencephalography (EEG) devices segment is expected to account for the largest market share during the forecast period due to their versatility in diagnosing and monitoring brain activity across multiple conditions. Applications in epilepsy, sleep disorders, and neurodegenerative diseases are driving institutional and outpatient adoption. Integration with portable and cloud-connected formats is improving usability and data access. Hospitals, neurology clinics, and research centers are scaling EEG infrastructure for real-time analysis. Advances in signal processing and artifact reduction are enhancing diagnostic precision. This segment remains the cornerstone of neurological monitoring protocols.
The wearable EEG devices segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the wearable EEG devices segment is predicted to witness the highest growth rate as demand for remote and continuous brain monitoring accelerates. Integration with mobile apps, cloud platforms, and AI analytics is expanding use in outpatient and home care settings. Applications in sleep tracking, seizure detection, and cognitive assessment are driving consumer and clinical interest. Lightweight form factors and wireless connectivity are improving patient comfort and compliance. Partnerships between medtech firms and digital health platforms are boosting visibility and adoption.
During the forecast period, the North America region is expected to hold the largest market share due to strong healthcare infrastructure, high diagnostic awareness, and favorable reimbursement frameworks. United States and Canada are scaling neurology monitoring across hospitals, research institutions, and home care networks. Investment in AI-enabled diagnostics and tele-neurology platforms is enhancing service delivery. Presence of leading device manufacturers and academic collaborations is driving innovation. Regulatory clarity and clinical integration are reinforcing market dominance. The region remains the benchmark for neurodiagnostic deployment.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR as healthcare systems expand and neurological disease burden rises. China, India, Japan, and Southeast Asia are scaling neurology monitoring through public health initiatives and private investment. Increased healthcare investments in emerging economies are accelerating access to EEG, EMG, and cerebral oximetry technologies. Local innovation in wearable formats and mobile diagnostics is improving affordability and reach. Demand for early detection and long-term care is driving rapid deployment.
Key players in the market
Some of the key players in Neurology Monitoring Market include Medtronic plc, Natus Medical Incorporated, Philips Healthcare, Nihon Kohden Corporation, GE Healthcare, Compumedics Limited, Masimo Corporation, Siemens Healthineers, Cadwell Industries, Inc., NeuroWave Systems Inc., NeuraSignal Solutions, Micromed Group, Neurosoft, Electrical Geodesics, Inc. (EGI) and Integra LifeSciences Holdings Corporation.
In September 2025, Natus acquired the remaining minority shares of Holberg EEG, securing full ownership of its AI-powered EEG interpretation platform. The acquisition enables Natus to accelerate deployment of autoSCORE, a clinically validated model for routine, ambulatory, and long-term EEG diagnostics.
In July 2025, Medtronic and Philips announced a multi-year partnership to enhance patient monitoring technology. This collaboration aims to improve patient care and expand access to advanced monitoring solutions.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.